Details for New Drug Application (NDA): 022470
✉ Email this page to a colleague
NDA 022470 describes NEXCEDE, which is a drug marketed by Novartis and is included in one NDA. Additional details are available on the NEXCEDE profile page.
The generic ingredient in NEXCEDE is ketoprofen. There are twenty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.
The generic ingredient in NEXCEDE is ketoprofen. There are twenty-seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the ketoprofen profile page.
Summary for 022470
| Tradename: | NEXCEDE |
| Applicant: | Novartis |
| Ingredient: | ketoprofen |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 022470
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FILM;ORAL | Strength | 12.5MG | ||||
| Approval Date: | Nov 25, 2009 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
